secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theravance Biopharma, Inc. (TBPH)
CIK:        0001583107
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001104659-26-002726
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theravance Biopharma holds investor meetings with January 2026 corporate slide deck; no new financials or guidance
--------------------------------------------------------------------------------

- Management team conducting one-on-one meetings with analysts and investors in San Francisco from Jan 12-15, 2026.
- Slide deck furnished as Exhibit 99.1 contains corporate overview but no material new information beyond prior disclosures.
- Filing under Regulation FD; no financial updates, pipeline changes, or guidance adjustments disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583107/000110465926002726/0001104659-26-002726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583107/000110465926002726/tm262807d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-002726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer